Ortivus AB

09/15/2021 | Press release | Distributed by Public on 09/15/2021 06:54

Ortivus is awarded a contract for defibrillators to Region Jönköping County's hospital care

Ortivus has been awarded a contract for the delivery of semi-automatic defibrillators to Region Jönköping County's hospital operations. The order value is estimated to 1.7 MSEK and the contract duration is 2 years with a possible extension for 1 + 1 years.

On December 10, 2020, Ortivus was awarded a contract for the delivery of equipment to Region Jönköping County's ambulance service. The region has now chosen to expand the collaboration by awarding Ortivus contract for semi-automatic defibrillators to their hospital operations. The contract applies to 100 units of the model Reanibex 100 (R100), which was launched in the spring of 2021 and is thus the latest model on the market.

The R100 is a part of Ortivus' MobiMed Life, which includes several external defibrillators from Bexen Cardio, for which Ortivus has exclusive distribution rights in the Nordic countries, the UK and Ireland.

'We are very pleased with this award, which is strategically important for Ortivus. The fact that Region Jönköping is once again choosing Ortivus means that our solutions are competitive and that our offering is in line with the customer demands' says Elias Obaid, Ortivus' sales manager.

This award decision does not mean that a contract has been signed and that contractual obligations applies. The contract can be signed after the contract lock has expired. The contract can earliest be signed within 10 days after the award decision has been announced.

Contacts

For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12 000 paramedics in over 2 700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 2.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2021-09-15 14:15 CEST.